FINRA has updated the SLATE Participant Specifications. Please email FINRA Client and System Management with questions regarding this notice.
SEC Approves Amendments to TRACE Reporting Requirements to Conform With Requirements in the Multi Product Platform
INFORMATIONAL
Nasdaq National Market Execution System
Effective Date: July 10, 2000
SUGGESTED ROUTING
KEY TOPICS
Institutional
Legal & Compliance
Operations
Senior Management
Systems
Trading & Market Making
Nasdaq National Market Execution System
SelectNet
Small Order Execution System
Trading
Executive Summary
On January 14, 2000, the Securities and
Guidance to Members Affected by Hurricane Sandy
SEC Approves Amendments to TRACE Reporting Requirements and Dissemination of Agency Pass-Through Mortgage-Backed Securities Traded To Be Announced and Related Fees
regulators , I should be able to choose the public
investments that are right for my family.
Public investments should be available to all of the public,
not just the wealthy.
I enjoy playing the stock market
There should not be any test to have to take to play or invest in the market. Some people have disabilities and I believe this could also become discrimination.
Im capable of
New Firm Requirement to Designate a Super Account Administrator
As a self-regulatory organization, information sharing is key to FINRA's pursuit of its mission of investor protection and market integrity. The 2025 FINRA Regulatory Oversight Report provides just that. On this episode, FINRA’s regulatory leaders join us to discuss key takeaways from the report.
Proposed Amendments to Qualification Examination Fees in Section 4(c) of Schedule A to the FINRA By-Laws
Dear FINRA Regulators,
I am a small investor who took an interest in ETF investments back in 2008, when a severe drop in the market had affected a great many people. At that time I reasoned that having the ability to engage the market in both directions, UP or DOWN, would be a critical component of my investment strategy. Since then I have employed both conservative and less risk-adverse
